CIRCUMVENT® PCV G2 has been shown effective for the vaccination of
healthy swine 3 days of age or 3 weeks or older against Porcine
Circovirus Type 2. Duration of immunity has been shown to be at least 20
weeks. For more information regarding efficacy and safety data, go to
productdata.aphis.usda.gov. This product has been shown to be effective
against viremia and reduction in viral shedding and lymphoid infection
caused by Porcine Circovirus Type 2. Composition: This product contains
a subunit vaccine based on Porcine Circovirus Type 2a.

▪The ONLY PCV2 vaccine that’s approved for use in pigs as young as 3
days of age (two-dose option)
▪Pigs are easier to handle, they are less likely to be stressed because
they are still with their mothers
▪Choose between two convenient options
▪One dose– single 2 mL intramuscular dose at 3 weeks of age or older
▪Same superior efficacy, now with five-month duration of immunity
▪Aids in the prevention of PCV2 viremia, which is the initial step in
the development of PCV2 disease
▪It’s more effective to control the disease early on so damage caused by
infection is limited or essentially eliminated
▪Helps predict ability of vaccine to perform in real-world conditions
▪Microsol Diluvac Forte® adjuvant provides optimal immune response